Dianthus Therapeutics (DNTH) Stock Chart & Stock Price History $19.62 -1.98 (-9.17%) Closing price 04:00 PM EasternExtended Trading$19.70 +0.08 (+0.41%) As of 04:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Dianthus Therapeutics Stock Price Performance 5 Day Performance-4.80%1 Month Performance-11.10%3 Month Performance-23.27%6 Month Performance-29.04%Year-To-Date Performance-10.00%1 Year Performance-23.81% Receive DNTH Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Dianthus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address DNTH Stock Chart for Monday, March, 3, 2025 DNTH Chart by TradingView Dianthus Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/03/2025$21.60$19.62-9.17%$21.60$19.44345,170 shs$580.69 million02/28/2025$21.05$21.60+2.61%$21.74$20.65378,335 shs$639.30 million02/27/2025$20.61$21.05+2.13%$21.79$20.57145,484 shs$623.02 million02/26/2025$22.00$20.61-6.32%$24.47$20.55190,343 shs$609.99 million02/25/2025$21.60$22.00+1.85%$22.36$21.50215,336 shs$651.13 million02/24/2025$23.67$21.60-8.75%$23.70$21.33232,046 shs$639.30 million02/21/2025$23.70$23.67-0.13%$24.83$23.37304,049 shs$700.63 million02/20/2025$23.34$23.70+1.54%$24.19$22.77125,781 shs$701.45 million02/19/2025$24.25$23.34-3.75%$24.52$22.81185,510 shs$690.86 million02/18/2025$24.49$24.25-0.98%$25.27$23.77274,269 shs$717.80 million Get the Latest News and Ratings for DNTH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Dianthus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 02/17/2025$24.49$24.49$25.46$23.61332,868 shs$724.90 million02/14/2025$24.13$24.49+1.49%$25.46$23.61332,868 shs$724.90 million02/13/2025$23.01$24.13+4.87%$24.20$22.03179,710 shs$714.25 million02/12/2025$23.36$23.01-1.50%$23.24$22.15199,163 shs$681.10 million02/11/2025$23.31$23.36+0.21%$23.82$22.83211,187 shs$691.46 million02/10/2025$23.05$23.31+1.13%$23.53$22.95148,457 shs$689.98 million02/07/2025$22.96$23.05+0.39%$23.61$22.70232,332 shs$682.21 million02/06/2025$24.73$22.96-7.16%$24.97$22.91384,597 shs$679.62 million02/05/2025$22.29$24.73+10.95%$24.82$22.03195,416 shs$732.01 million02/04/2025$22.07$22.29+1.00%$22.43$21.3997,661 shs$659.78 million02/03/2025$22.15$22.07-0.36%$22.52$21.28125,579 shs$653.27 million Related Companies Beam Therapeutics Stock Price Chart Catalyst Pharmaceuticals Stock Price Chart Twist Bioscience Stock Price Chart Mirum Pharmaceuticals Stock Price Chart Arrowhead Pharmaceuticals Stock Price Chart Edgewise Therapeutics Stock Price Chart Gemini Therapeutics Stock Price Chart Kymera Therapeutics Stock Price Chart ImmunityBio Stock Price Chart Protagonist Therapeutics Stock Price Chart Receive DNTH Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Dianthus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:DNTH) was last updated on 3/3/2025 by MarketBeat.com Staff From Our PartnersDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredUrgent update to my gold outlookTrump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored3 Undervalued Stocks to Get Today (Revealed)These 3 Stocks Should Do Well Even in a Recession If you’re looking for stocks that offer significant upsid...StockEarnings | SponsoredCollect $7k per month from Tesla’s SECRET dividendThere's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a tra...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dianthus Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Dianthus Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DNTH Stock Alerts